AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024
Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference. Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development. Read More →
Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials
Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at SCOPE 2024 by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem. Read More →
Join QuartzBio at SCOPE 2024 | Booth #300
Join QuartzBio at SCOPE 2024, the Summit for Clinical Operations Executives, at Booth 300. We'll be presenting “Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials” here you’ll learn about deploying generative AI in drug development. Read More →
Webinar On Demand: Taming clinical sample chaos with conversational AI
Learn how conversational AI enables you to talk to your biospecimen data. Join Bill Hall for a demo of our virtual Sample Inventory Management solution, powered by an AI-enabled Biomarker Intelligence Platform and intuitive Virtual Assistant. Read More →